Views Navigation

Event Views Navigation

Today

Co-occurring Opioid and Stimulant Use Disorders: Treatment and Management Approaches

Register Now Presenters: Jonathan Craig Allen, MD, FASAM, and Marc Fishman, MD Sponsor: National Council for Mental Wellbeing--NCMW Continuing education information: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME credit, SW CE credit, Pharmacy CE credit and IPCE credit Target Audience: This activity is designed for physicians, nurses, PAs, pharmacists, social […]

Treatment Considerations in the Age of Fentanyl

Fentanyl and other high-potency synthetic opioids are increasingly present in the U.S. drug supply. Healthcare systems, treatment providers, and justice systems are grappling with the physiological consequences of chronic fentanyl use and how its use may impact treatment. Speakers: - Kathryn Cates-Wessel, CEO, American Academy of Addiction Psychiatry - John J. Mariani, MD, Associate Professor […]

Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms of an Evidence-Based Therapy for Chronic Pain, Opioid Misuse, and Opioid Use Disorder

Register Now   Presenter: Eric Garland, PhD, LCSW Sponsoring organization: American Society for Pain Management Nursing (ASPMN) Target audience: Clinical providers including Physicians, PAs and NPs About the webinar: Half of all people with a substance use disorder (SUD) have chronic pain, and more than a third have a co-occurring psychiatric disorder. The ongoing opioid crisis is a […]

Initiating Buprenorphine for Patients Using Fentanyl

Register Now Presenter: Brian Hurley, MD, MBA, DFASAM, FAPA Cost: No Fee Target audience: Nurses, Addictions Specialists, SUD Project Directors, Managers, and Facilitators and MOUD (medications for opioid use disorder) providers Credit Designations Available: Nursing CE Webinar description: This webinar will review variations on buprenorphine dosing that can be considered for patients with opioid use disorder involving fentanyl. The […]

Xylazine and How it Harms People Who Use Drugs

Register now! Presenters: Raagini Jawa, MD Cost: No fee Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. Description: We will review what is known to date on Xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US. This […]

Opioid Use Disorder and Social Determinants of Health

Presenters:   Rachel Talley, MD, Assistant Professor of Clinical Psychiatry/Director, Fellowship in Public and Community Psychiatry Jessica Isom, MD, Attending Psychiatrist, Codman Square Health Center/Clinical Instructor, Yale University/Faculty Lead, Social […]

Drug Use in Pregnancy (ASAM FAME Session 7)

Register Now Questions about registering should be directed to: ASAM Education by email ateducation@asam.org Presenters: Abby Letcher, MD, FASAM Angela Colistra, PhD, LPC, CAADC, CCS Shanna Diaz, DO Leslie Hayes, […]

Buprenorphine Dosing and Preparations in the Era of Fentanyl

Presenters: Gail D’Onofrio, MD and Andrew Herring, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity […]

Ready or Not Here Come the Nitazenes

Presenter: Edwin Salsitz, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round […]

Women & Alcohol: What does stress have to do with it?

Join us on Wednesday, November 15th for the #VCBHLectureSeries as we welcome Sherry McKee, PhD, Director, Yale Behavioral Pharmacology Laboratory. Dr. McKee will present "Women & Alcohol: What does stress […]

Collaborative Care Model (CoCM) for Substance Use Disorders

Presenters: Anna Ratzliff, MD, PhD; Jasen Christensen, DO Webinar Description This presentation will review the Collaborative Care Model (CoCM), which is an evidence-based approach to delivering behavioral healthcare in primary care settings. This model has been adapted to address substance use disorders in primary medical settings. CoCM requires a team of providers; trained primary care […]

Overdose-related Compassion Fatigue in Rural Communities

Erin Winstanley, PhD Visiting Professor, University of Pittsburgh School of Medicine Dr. Winstanley received her doctoral degree from The Johns Hopkins Bloomberg School of Public Health, she has postdoctoral training in behavioral pharmacology, and she has over 20 years of experience as a behavioral health services researcher. Dr. Winstanley's current research is focused on reducing […]

Treating Adolescents with Substance Use Disorder

Presenter: Marc Fishman, MD Target Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal "round table" conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. Register now

Northern New England ASAM Annual Conference

Conference Agenda Day One: 5 PM – 6:30 PM:            Conference Check-in and Welcome Reception Refreshments and social hour. 6:30 PM – 7:30 PM:     […]

$25 – $150

Northern New England ASAM Annual Conference

Conference Agenda Day Two: 8:30 AM – 8:45 AM:    Welcome Remarks Clifton “Fred” Lord MD, President of NNESAM, ASAM Fellow, Board Certified in Addiction Medicine, CEO/Medical Director/Chairman of the […]

$25 – $150